The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Triplet chemotherapy (TC) with FOLFIRINOX regimen in metastatic colorectal cancer (mCRC): Experience of the Val d’Aurelle Center.
Emmanuelle Samalin
No relevant relationships to disclose
Virginie Loriot
No relevant relationships to disclose
Simon Th├ęzenas
No relevant relationships to disclose
Eric Assenat
No relevant relationships to disclose
Fabienne Portales
No relevant relationships to disclose
Sebastien Carrere
No relevant relationships to disclose
Philippe Rouanet
No relevant relationships to disclose
Jean-Pierre Bleuse
No relevant relationships to disclose
Francois Quenet
No relevant relationships to disclose
Marc Ychou
No relevant relationships to disclose